Manjusha Gaglani

Overview

Best Publications

• Interim Estimates of Vaccine Effectiveness of BNT162b2 and mRNA-1273 COVID-19 Vaccines in Preventing SARS-CoV-2 Infection Among Health Care Personnel, First Responders, and Other Essential and Frontline Workers - Eight U.S. Locations, December 2020-March 2021.

  Mark G. Thompson;Jefferey L. Burgess;Allison L. Naleway;Harmony L. Tyner

  834
  Citations

• Waning 2-Dose and 3-Dose Effectiveness of mRNA Vaccines Against COVID-19–Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Adults During Periods of Delta and Omicron Variant Predominance — VISION Network, 10 States, August 2021–January 2022

  Unknown

  789
  Citations

• Effectiveness of a Third Dose of mRNA Vaccines Against COVID-19–Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Adults During Periods of Delta and Omicron Variant Predominance — VISION Network, 10 States, August 2021–January 2022

  Unknown

  761
  Citations

• Clinical severity of, and effectiveness of mRNA vaccines against, covid-19 from omicron, delta, and alpha SARS-CoV-2 variants in the United States: prospective observational study

  Unknown

  677
  Citations

• Association Between mRNA Vaccination and COVID-19 Hospitalization and Disease Severity.

  Mark W Tenforde;Wesley H Self;Katherine Adams;Manjusha Gaglani

  657
  Citations

• Prevention and Attenuation of Covid-19 with the BNT162b2 and mRNA-1273 Vaccines.

  Mark G Thompson;Jefferey L Burgess;Allison L Naleway;Harmony Tyner

  515
  Citations

• Effectiveness of Covid-19 Vaccines in Ambulatory and Inpatient Care Settings.

  Mark G Thompson;Edward Stenehjem;Shaun Grannis;Sarah W Ball

  469
  Citations

• Comparative Effectiveness of Moderna, Pfizer-BioNTech, and Janssen (Johnson & Johnson) Vaccines in Preventing COVID-19 Hospitalizations Among Adults Without Immunocompromising Conditions - United States, March-August 2021.

  Wesley H. Self;Mark W. Tenforde;Jillian P. Rhoads;Manjusha Gaglani;Manjusha Gaglani

  425
  Citations

• Influenza Vaccine Effectiveness in the 2011–2012 Season: Protection Against Each Circulating Virus and the Effect of Prior Vaccination on Estimates

  Suzanne E. Ohmit;Mark G. Thompson;Joshua G. Petrie;Swathi N. Thaker

  406
  Citations

• Effectiveness of school-based influenza vaccination.

  James C. King;Jeffrey J. Stoddard;Manjusha J. Gaglani;Kristine A. Moore

  379
  Citations

• Herd immunity in adults against influenza-related illnesses with use of the trivalent-live attenuated influenza vaccine (CAIV-T) in children.

  Pedro A. Piedra;Manjusha J. Gaglani;Claudia A. Kozinetz;Gayla Herschler

  353
  Citations

• Influenza vaccine effectiveness in the United States during the 2015-2016 season.

  Michael L. Jackson;Jessie R. Chung;Lisa A. Jackson;C. Hallie Phillips

  338
  Citations

• Effectiveness of COVID-19 Pfizer-BioNTech BNT162b2 mRNA Vaccination in Preventing COVID-19–Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Nonimmunocompromised Children and Adolescents Aged 5–17 Years — VISION Network, 10 States, April 2021–January 2022

  Unknown

  319
  Citations

• Influenza Vaccine Effectiveness in the United States During 2012–2013: Variable Protection by Age and Virus Type

  Huong Q. McLean;Mark G. Thompson;Maria E. Sundaram;Burney A. Kieke

  318
  Citations

• Effects of Influenza Vaccination in the United States During the 2017-2018 Influenza Season.

  Melissa A Rolfes;Brendan Flannery;Jessie R Chung;Alissa O'Halloran

  312
  Citations

• Effectiveness of 2-Dose BNT162b2 (Pfizer BioNTech) mRNA Vaccine in Preventing SARS-CoV-2 Infection Among Children Aged 5–11 Years and Adolescents Aged 12–15 Years — PROTECT Cohort, July 2021–February 2022

  Unknown

  310
  Citations

• Waning of vaccine effectiveness against moderate and severe covid-19 among adults in the US from the VISION network: test negative, case-control study

  Unknown

  298
  Citations

• Effectiveness of COVID-19 Vaccines in Preventing SARS-CoV-2 Infection Among Frontline Workers Before and During B.1.617.2 (Delta) Variant Predominance - Eight U.S. Locations, December 2020-August 2021.

  Ashley Fowlkes;Manjusha Gaglani;Kimberly Groover;Matthew S Thiese

  297
  Citations

• 2014-2015 Influenza Vaccine Effectiveness in the United States by Vaccine Type.

  Richard K Zimmerman;Mary Patricia Nowalk;Jessie Chung;Michael L Jackson

  294
  Citations

• Effectiveness of Pfizer-BioNTech and Moderna Vaccines Against COVID-19 Among Hospitalized Adults Aged ≥65 Years - United States, January-March 2021.

  Mark W. Tenforde;Samantha M. Olson;Wesley H. Self;H. Keipp Talbot

  278
  Citations

• Early Estimates of Seasonal Influenza Vaccine Effectiveness — United States, January 2015

  Brendan Flannery;Jessie Clippard;Richard K. Zimmerman;Mary Patricia Nowalk

  256
  Citations

• Sustained Effectiveness of Pfizer-BioNTech and Moderna Vaccines Against COVID-19 Associated Hospitalizations Among Adults - United States, March-July 2021.

  Mark W. Tenforde;Wesley H. Self;Eric A. Naioti;Adit A. Ginde

  223
  Citations

• Interim Estimates of 2017-18 Seasonal Influenza Vaccine Effectiveness - United States, February 2018.

  Brendan Flannery;Jessie R. Chung;Edward A. Belongia;Huong Q. McLean

  222
  Citations

• Spread of Antigenically Drifted Influenza A(H3N2) Viruses and Vaccine Effectiveness in the United States During the 2018-2019 Season.

  Brendan Flannery;Rebecca J Garten Kondor;Jessie R Chung;Manjusha Gaglani

  219
  Citations

• Prevention and Attenuation of COVID-19 by BNT162b2 and mRNA-1273 Vaccines

  Mark G Thompson;Jefferey L Burgess;Allison Naleway;Harmony Tyner

  135
  Citations

• Influenza Vaccine Effectiveness in the United States During the 2016–2017 Season

  Brendan Flannery;Jessie R Chung;Arnold S Monto;Emily T Martin

  125
  Citations